Using PICCs in Cancer Patients
By: Health Line Sales and Marketing -January 2017
A study completed comparing the safeness and effectiveness of using Health Line peripherally inserted central catheters (PICCs) in place of central venous catheters for various cancer treatments confirms PICCs are a “safe venous device for chemotherapy delivery.”
Synergy CT PICC lines were implanted into a total of 291 cancer patients receiving “chemotherapy and/or associated supportive nutritional therapy at fixed intervals of time” depending on the patient.
The study was done from January 1, 2012, to June 1, 2014, and concluded,
PICCs can be considered safe and reliable to deliver chemotherapy in particular during the early 2-3 months after implant. Nevertheless, physicians must be aware that failure may over in almost 15% of them, thus potentially overcoming the majority of PICC claimed advantages. Chemotherapy patients with risk factors with failure, in particular, previous DVT of the necessity of larger than 5F catheters, should be considered for an alternative vascular access device.”
For access to the full article, contact one of Health Line’s representatives.
Source: Sergio Bertogliom Beatrice Faccini, Luca Lallo, Ferdinando Cafiero and Paolo Bruzzi. "Peripherally Inserted Central Catheters (PICCs) in Cancer Patients Under Chemotherapy: A Prospective Study on the Incidence of Complications and Overall Failures." Journal of Surgical Oncology, 2016 (1-7).